[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
$numif
Cybin's Phase X EMBRACE study receives MHRA approval. The study aims to enroll XXX participants, generating significant positive sentiment.
About $numif
A financial and social analysis of the topic $numif.
Insights #
- $numif creators is up XXX% from the previous week.
- $numif mentions is up XXXXX% from the previous month.
- $numif Creators hit a high of X for the day
- $numif Creators hit an all time of X for the day
Engagements: XXX #
Engagements 24-Hour Chart Data
Current Value: XXX
Daily Average: XXX
1 Month: XXXXX -XX%
1-Year High: XXXXX on 2025-06-10
1-Year Low: X on 2025-05-10
| Social Network | X |
|---|---|
| Engagements | XXX |
Mentions: XX #
Mentions 24-Hour Chart Data
Current Value: XX
Daily Average: X
1 Week: XX +14%
1 Month: XX +32%
1-Year High: XX on 2025-07-12
1-Year Low: X on 2025-05-01
| Social Network | X |
|---|---|
| Mentions | XX |
Creators: X #
Creators 24-Hour Chart Data
X unique social accounts have posts mentioning $numif in the last XX hours which is down XX% from X in the previous XX hours
Daily Average: X
1 Week: X +300%
1 Month: XX +150%
1-Year High: X on 2025-07-19
1-Year Low: X on 2025-05-01
The most influential creators that mention $numif in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @psil_ai | X | XX | X | XXX |
Sentiment: XXX% #
Sentiment 24-Hour Chart Data
Current Value: XXX%
Daily Average: XXX%
1 Month: XXX% no change
1-Year High: XXX% on 2025-06-03
1-Year Low: XXX% on 2025-06-03
Most Supportive Themes
- Cybin's Phase X EMBRACE Study:: (100%) Cybin's Phase X EMBRACE study receives MHRA approval, aiming to enroll XXX participants across multiple sites, indicating progress in developing new treatments for MDD.
Most Critical Themes
Network engagement breakdown:
| Network | Positive | % | Neutral | % | Negative | % |
|---|---|---|---|---|---|---|
| X | XX | XX% | XX | X% | X | X% |
| Total | XX | XX% | XX | X% | X | X% |
Top assets mentioned In the posts about $numif in the last XX hours
Top topics mentioned In the posts about $numif in the last XX hours
$rvvtf, $atai, $cmps, $mnmd, $psyk, $numi, $psil, pfe, investment, stocks, acquisition, $psy, $ghrs, $numiv, $iwin, $iwinf, analog, $phrrf, $mmed, $mmedn, money, $trypf, iwc, spy, $iwc, $iwm, $awknf, $pbm, $ixhl, $nrxp, $lsdi, $rlmd, qqq, $qqq, jan, $psycf, approved, $cybn, $lkysf
Top Social Posts #
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
""Phase X study EMBRACE part of PARADIGM program approved by UK MHRA for CYB003 receives Breakthrough Therapy Designation from FDA for MDD." #clinicaltrials #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-18 19:01:19 UTC XX followers, XXX engagements
""#Cybin's Phase X study EMBRACE to enroll XXX participants at XX sites in US Europe & Australia. Approval from UK MHRA marks progress in developing new treatments for MDD. #innovation" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-18 16:01:10 UTC XX followers, XXX engagements
""CYBN receives MHRA approval for Phase X EMBRACE study expected to enroll XXX participants at XX sites. Potential to transform MDD treatment." #innovation #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-18 13:01:17 UTC XX followers, XXX engagements
""Cybin's Phase X PARADIGM program progresses with MHRA approval for EMBRACE study aiming to enroll XXX participants and generate critical data for CYB003 in treating MDD. #pharmaceuticals" #MentalHealth $CYBN $CMPS $ATAI $MNMD $NUMIF $RVVTF"
@psil_ai on X 2025-07-17 16:01:01 UTC XX followers, XXX engagements